Show simple item record

dc.contributor.authorBraude, Philip
dc.contributor.authorCarter, Ben
dc.contributor.authorShort, Roxanna
dc.contributor.authorVilches-Moraga, Arturo
dc.contributor.authorVerduri, Alessia
dc.contributor.authorLyndsay Pearce, Miss
dc.contributor.authorAngeline Price, Miss
dc.contributor.authorQuinn, Terence J
dc.contributor.authorStechman, Michael
dc.contributor.authorCollins, Jemima
dc.contributor.authorBruce, Eilidh
dc.contributor.authorEinarsson, Alice
dc.contributor.authorRickard, Frances
dc.contributor.authorMitchell, Emma
dc.contributor.authorHolloway, Mark
dc.contributor.authorHesford, James
dc.contributor.authorBarlow-Pay, Fenella
dc.contributor.authorClini, Enrico
dc.contributor.authorKyaw Myint, Phyo
dc.contributor.authorMoug, Susan
dc.contributor.authorMcCarthy, Kathryn
dc.contributor.authorHewitt, Jonathan
dc.date.accessioned2020-11-03T16:42:01Z
dc.date.available2020-11-03T16:42:01Z
dc.date.issued2020-12
dc.identifier.citationBraude , P , Carter , B , Short , R , Vilches-Moraga , A , Verduri , A , Lyndsay Pearce , M , Angeline Price , M , Quinn , T J , Stechman , M , Collins , J , Bruce , E , Einarsson , A , Rickard , F , Mitchell , E , Holloway , M , Hesford , J , Barlow-Pay , F , Clini , E , Kyaw Myint , P , Moug , S , McCarthy , K & Hewitt , J 2020 , ' The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19 ' , IJC Heart & Vasculature , vol. 31 , 100660 . https://doi.org/10.1016/j.ijcha.2020.100660en
dc.identifier.issn2352-9067
dc.identifier.otherPURE: 178984888
dc.identifier.otherPURE UUID: 939e389a-b4d2-45c0-94ed-15c1a2b8f41b
dc.identifier.otherPubMed: 33083516
dc.identifier.otherPubMedCentral: PMC7561344
dc.identifier.otherScopus: 85094813576
dc.identifier.urihttps://hdl.handle.net/2164/15310
dc.descriptionPublisher Copyright: © 2020 The Authors Copyright: Copyright 2020 Elsevier B.V., All rights reserved.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofIJC Heart & Vasculatureen
dc.rightsThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)en
dc.subjectCoronavirusen
dc.subjectAngiotensin receptor antagonistsen
dc.subjectangiotensin-converting enzyme inhibitorsen
dc.subjecthospitalizationen
dc.subjecthospital mortalityen
dc.subjectAngiotensin-converting enzyme inhibitorsen
dc.subjectHospital mortalityen
dc.subjectHospitalizationen
dc.subjectR Medicineen
dc.subjectCardiology and Cardiovascular Medicineen
dc.subject.lccRen
dc.titleThe influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.ijcha.2020.100660
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85094813576&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record